Drawing for VITAMEND

USPTO serial 99705293

VITAMEND

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
ABID, NABEELA
Law office
TMO LAW OFFICE 132

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with VITAMEND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Walter Joseph Tencza, Jr.

Walter Joseph Tencza, Jr. Walter J. Tencza Jr.100 Menlo Park, Suite 210Edison, NJ 08837United States

Goods and services

ClassDescriptionStatusFirst use
044Medical services, namely, providing ketamine infusions for mental health support, relief from chronic pain, and aiding; Medical services, namely, ketamine IV infusion and functional medicine; Medical services, namely, nicotinamide adenine dinucleotide (NAD+) infusions, longevity treatments vitamin injections; Health care services, namely, pain management services; Behavioral health services; Behavioral health services in the nature of outpatient ketamine treatment services; Medical clinic services; Mental health services; Medical consultations; Wellness and health-related consulting services; Mental health therapy services; Psychotherapy; Cognitive-behavioral therapy (CBT); Health care services, namely, intravenous hydration therapy, intravenous vitamin infusion therapy, intravenous antioxidant infusion therapy, intravenous electrolyte infusion therapy, intravenous amino acid infusion therapy, and intravenous hangover alleviation therapy; Health care services, namely, medicinal infusions in the nature of intravenous vitamin therapy services; Health care services, namely, medical micronutrient IV therapy for relief of stress, depression, anxiety, and enhancing overall wellness, including improvements in energy, inflammation reduction, assistance with hydration, and vitamin supplements support for the immune system, namely, wellness programsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Jul 20, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 17, 2026DOCKASSIGNED TO EXAMINER—
Jul 16, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 16, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 16, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance